Pediatric guidelines: help or hindrance?

C J Homer1, R G Grossman, J Rodman

  • 1Department of Pediatrics, Children's Hospital, Boston, MA 02115, USA.

Insights

Pediatric clinical guidelines aim to improve care quality by reducing variability. While rigorously developed, their actual impact on practice and patient outcomes remains undetermined.

Area of Science:

  • Pediatric medicine
  • Healthcare quality improvement

Background:

  • Clinical guidelines are increasingly central to pediatric practice.
  • They serve as a tool for assessing and enhancing care quality.
  • Current guidelines employ rigorous development methods, distinguishing them from older consensus approaches.

Purpose of the Study:

  • To highlight the growing role and development of clinical guidelines in pediatrics.
  • To discuss the application of guidelines for improving pediatric patient care.
  • To address the uncertainty surrounding the real-world effectiveness of these guidelines.

Main Methods:

  • Review of the development and application of pediatric clinical guidelines.
  • Examination of guidelines published by organizations like the American Academy of Pediatrics.
  • Analysis of strategies for implementing guidelines into practice.

Main Results:

  • The American Academy of Pediatrics has developed guidelines for numerous common pediatric conditions.
  • Guidelines cover areas such as asthma, hyperbilirubinemia, febrile seizures, gastroenteritis, and otitis media with effusion.
  • Strategies for guideline implementation are becoming more sophisticated.

Conclusions:

  • Pediatric clinical guidelines are a significant development in medical practice.
  • Despite rigorous development and implementation strategies, their ultimate effect on clinical practice and patient outcomes requires further investigation.

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...